CD19 and systemic lupus erythematosus: We reported previously that the proportions of CD19+IgD−CD27+ class-switched memory B cells and CD19+IgD−CD27− effector memory B cells tended to be higher in the peripheral blood of refractory SLE patients than in that of the control [16–18].